Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Gross Margin % : 82.48% (As of Nov. 2023)

Cannabis Bioscience International Holdings Gross Margin % Chart

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
Gross Margin %	Get a 7-Day Free Trial							28.36	37.75	34.09	75.80	82.48

Competitive Comparison of Cannabis Bioscience International Holdings's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Bioscience International Holdings's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Gross Margin % falls into.

Cannabis Bioscience International Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Cannabis Bioscience International Holdings's Gross Margin for the fiscal year that ended in May. 2011 is calculated as

Cannabis Bioscience International Holdings's Gross Margin for the quarter that ended in Nov. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Cannabis Bioscience International Holdings  (OTCPK:CBIH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Cannabis Bioscience International Holdings had a gross margin of 82.48% for the quarter that ended in Nov. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Cannabis Bioscience International Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description